TG Therapeutics (TGTX) Outpaces Stock Market Gains: What You …

Feb 15, 2023 · TG Therapeutics (TGTX) closed at $19.34 in the latest trading session, marking a +1.79% move from the prior day. This change outpaced the S&P 500's 0.28% gain on the day.

79%
OFF

TG Therapeutics (TGTX) Outpaces Stock Market Gains: What You …

2 weeks from now

Feb 15, 2023 · TG Therapeutics (TGTX) closed at $19.34 in the latest trading session, marking a +1.79% move from the prior day. This change outpaced the S&P 500's 0.28% gain on the day.

yahoo.com

61%
OFF

TG Therapeutics (TGTX) Outpaces Stock Market Gains: What You …

2 weeks from now

Jan 12, 2023 · In the latest trading session, TG Therapeutics (TGTX) closed at $13.20, marking a +0.61% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.34%.

yahoo.com

61%
OFF

TG Therapeutics (TGTX) Outpaces Stock Market Gains: What You …

2 weeks from now

Jan 12, 2023 · TG Therapeutics (TGTX) closed at $13.20 in the latest trading session, marking a +0.61% move from the prior day. TG Therapeutics (TGTX) Outpaces Stock Market Gains: …

zacks.com

27%
OFF

TG Therapeutics (TGTX) Stock Sinks As Market Gains: What You …

2 weeks from now

TG Therapeutics (TGTX) closed the most recent trading day at $18.43, moving -0.27% from the previous trading session. This move lagged the S&P 500's daily gain of 1.29%.

yahoo.com

5%
OFF

TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?

2 weeks from now

15 hours ago · TG Therapeutics (TGTX Quick Quote TGTX - Free Report) shares ended the last trading session 7.5% higher at $29.74. The jump came on an impressive volume with a higher …

zacks.com

27%
OFF

TG Therapeutics (TGTX) Stock Sinks As Market Gains: What You

2 weeks from now

Feb 7, 2023 · TG Therapeutics (TGTX) closed the most recent trading day at $18.43, moving -0.27% from the previous trading session. This move lagged the S&P 500's daily gain of …

nasdaq.com

61%
OFF

TG Therapeutics (TGTX) Outpaces Stock Market Gains: What You …

2 weeks from now

TG Therapeutics (TGTX) closed at $13.20 in the latest trading session, marking a +0.61% move from the prior day.

barchart.com

61%
OFF

TG Therapeutics (TGTX) Outpaces Stock Market Gains: What You …

2 weeks from now

Jan 12, 2023 · In the latest trading session, TG Therapeutics (TGTX) closed at $13.20, marking a +0.61% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.34%. …

nasdaq.com

79%
OFF

TG Therapeutics (TGTX) Outpaces Stock Market Gains: What You …

2 weeks from now

Feb 15, 2023 · TG Therapeutics (TGTX) closed at $19.34 in the latest trading session, marking a +1.79% move from the prior day. This change outpaced the S&P 500's 0.28% gain on the day. …

nasdaq.com

8%
OFF

What's Going On With TG Therapeutics Stock Tuesday?

2 weeks from now

1 day ago · TGTX Price Action: TG Therapeutics shares were up 7.8% at $29.85 at the time of publication, according to Benzinga Pro. Photo: Shutterstock. Market News and Data brought to …

benzinga.com

9%
OFF

Why TGTX Stock Is Rallying Today - Insider Monkey

2 weeks from now

19 hours ago · The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, …

insidermonkey.com

9%
OFF

Why TGTX Stock Is Rallying Today - Yahoo Finance

2 weeks from now

19 hours ago · The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, …

yahoo.com

20%
OFF

TG Therapeutics (TGTX) Upgraded To Buy: What Does It Mean For …

2 weeks from now

Jan 9, 2023 · The upgrade of TG Therapeutics to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move …

nasdaq.com

$537
OFF

TG Therapeutics Stock Rises On Strong Q4 And Full-year Revenue

2 weeks from now

1 day ago · Market consensus for TG Therapeutics' 2025 revenue is slightly below the company's target at $537.8 million, indicating that the firm's guidance is in line with analyst expectations.

investing.com

$55
OFF

TG Therapeutics Price Target Raised To $55 From $49 At H.C

2 weeks from now

Nov 4, 2024 · H.C. Wainwright raised the firm’s price target on TG Therapeutics (TGTX) to $55 from $49 and keeps a Buy rating on the shares. TG Therapeutics reported Q3 results, …

nasdaq.com

79%
OFF

TG Therapeutics (TGTX) Outpaces Stock Market Gains: What You …

2 weeks from now

TG Therapeutics (TGTX) closed at $19.34 in the latest trading session, marking a +1.79% move from the prior day.

barchart.com

$0.03
OFF

TG Therapeutics (TGTX) Earnings Date And Reports 2025

2 weeks from now

2 days ago · In the previous quarter, TG Therapeutics (NASDAQ:TGTX) missed the analysts' consensus estimate of $0.03 by $0.01 with a reported earnings per share (EPS) of $0.02. …

marketbeat.com

FAQs about TG Therapeutics (TGTX) Outpaces Stock Market Gains: What You … Coupon?

What happened to TG Therapeutics (tgtx)?

In the latest trading session, TG Therapeutics (TGTX) closed at $13.20, marking a +0.61% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.34%. At the same time, the Dow added 0.64%, and the tech-heavy Nasdaq gained 8.98%. ...

Where can I buy shares of TG Therapeutics?

Shares of TGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of TG Therapeutics own? ...

Should you buy TG Therapeutics (tgtx) stock now?

TG Therapeutics (TGTX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The Zacks rating relies solely on a company's changing earnings picture. ...

When will TG Therapeutics (TG) earnings come out?

Earnings for TG Therapeutics are expected to grow by 538.46% in the coming year, from $0.13 to $0.83 per share. TG Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off prior year's report dates. ...

Is TG Therapeutics a good buy in the medical - products industry?

TG Therapeutics is holding a Zacks Rank of #2 (Buy) right now. The Medical - Products industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 157, which puts it in the bottom 38% of all 250+ industries. ...

Why is TG Therapeutics struggling?

The industry is also subject to political and economic pressures, including changes in healthcare policy and pricing pressures from payers. TG Therapeutics faces competition from other companies developing cancer and autoimmune disease treatments, including large pharmaceutical companies such as Roche and Novartis. ...